Testing effectiveness (Phase 2)Active Not RecruitingNCT06237881
What this trial is testing
KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors
Who this might be right for
Advanced Solid TumorMelanomaLung Neoplasms+1 more
M.D. Anderson Cancer Center 15